Stock Earnings

Question 1

What are Plum Acquisition Corp. IV's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), CytomX Therapeutics Inc has a total asset of $151, Net loss of $-20

Question 2

What are the key financial ratios for PLMKW?

Accepted Answer

CytomX Therapeutics Inc's Current ratio is 2.9, has a Net margin is -26.31, sales per share of $0.55.

Question 3

How is Plum Acquisition Corp. IV's revenue broken down by segment or geography?

Accepted Answer

CytomX Therapeutics Inc largest revenue segment is Probody Therapeutics, at a revenue of 138,103,000 in the most earnings release.For geography, United States is the primary market for CytomX Therapeutics Inc, at a revenue of 138,103,000.

Question 4

Is Plum Acquisition Corp. IV profitable?

Accepted Answer

no, according to the latest financial statements, CytomX Therapeutics Inc has a net loss of $-20

Question 5

Does Plum Acquisition Corp. IV have any liabilities?

Accepted Answer

yes, CytomX Therapeutics Inc has liability of 52

Question 6

How many outstanding shares for Plum Acquisition Corp. IV?

Accepted Answer

CytomX Therapeutics Inc has a total outstanding shares of 170.18

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	76	76	138	101	53	37
Revenue Growth (YoY)	-45%	-45%	37%	91%	43%	-63%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	29	29	29	30	40	39
Research & Development	68	68	83	77	106	114
Operating Expenses	98	98	113	107	146	153
Other Non Operating Income (Expenses)	0	0	0	0	0	0
Pretax Income	-17	-17	32	3	-99	-115
Income Tax Expense	0	0	0	3	0	0
Net Income	-20	-20	31	0	-99	-115
Net Income Growth	-165%	-165%	--	-100%	-14%	259%
Shares Outstanding (Diluted)	169.68	137.93	84.74	73.8	65.7	64.1
Shares Change (YoY)	98%	63%	15%	12%	3%	39%
EPS (Diluted)	-0.12	-0.14	0.37	0	-1.51	-1.81
EPS Growth	-132%	-139%	-4,984%	-99%	-17%	155%
Free Cash Flow	-75	-75	-86	-56	-112	-120
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	-28.94%	-28.94%	17.39%	-5.94%	-175.47%	-313.51%
Profit Margin	-26.31%	-26.31%	22.46%	0%	-186.79%	-310.81%
Free Cash Flow Margin	-98.68%	-98.68%	-62.31%	-55.44%	-211.32%	-324.32%
EBITDA	-21	-21	25	-4	-91	-114
EBITDA Margin	-27.63%	-27.63%	18.11%	-3.96%	-171.69%	-308.1%
D&A For EBITDA	1	1	1	2	2	2
EBIT	-22	-22	24	-6	-93	-116
EBIT Margin	-28.94%	-28.94%	17.39%	-5.94%	-175.47%	-313.51%
Effective Tax Rate	0%	0%	0%	100%	0%	0%

Plum Acquisition Corp. IV (PLMKW) Financial

PLMKW Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

PLMKW Income

Follow-Up Questions